Format
Items per page

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Tetrathiomolybdate

MedGen UID:
35368
Concept ID:
C0076339
Inorganic Chemical; Pharmacologic Substance
2.

Suppression

MedGen UID:
526147
Concept ID:
C0221103
Pathologic Function
3.

Metastasis

The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor. [from NCI]

MedGen UID:
45032
Concept ID:
C0027627
Neoplastic Process
4.

Copper

A heavy metal trace element with the atomic symbol Cu, atomic number 29, and atomic weight 63.55. [from MeSH]

MedGen UID:
40479
Concept ID:
C0009968
Biologically Active Substance; Element, Ion, or Isotope; Pharmacologic Substance
5.

Carcinoma

MedGen UID:
2867
Concept ID:
C0007097
Neoplastic Process
6.

Carcinoma

MedGen UID:
910818
Concept ID:
CN241453
Finding
7.

Furriers lung

MedGen UID:
538594
Concept ID:
C0264476
Disease or Syndrome
8.

Coffee-workers lung

MedGen UID:
538589
Concept ID:
C0264468
Disease or Syndrome
9.

Cheese-washers lung

MedGen UID:
507549
Concept ID:
C0007969
Disease or Syndrome
10.

Breast carcinoma

MedGen UID:
146260
Concept ID:
C0678222
Neoplastic Process
11.

Inflammatory Breast Carcinoma

An advanced, invasive breast adenocarcinoma characterized by the presence of distinct changes in the overlying skin. These changes include diffuse erythema, edema, peau d'orange (skin of an orange) appearance, tenderness, induration, warmth, enlargement, and in some cases a palpable mass. The skin changes are the consequence of lymphatic obstruction from the underlying invasive breast adenocarcinoma. Microscopically, the dermal lymphatics show prominent infiltration by malignant cells. The invasive breast adenocarcinoma is usually of ductal, NOS type. There is not significant inflammatory cell infiltrate present, despite the name of this carcinoma. [from NCI]

MedGen UID:
75841
Concept ID:
C0278601
Neoplastic Process
12.

Growth substance

Signal molecules that are involved in the control of cell growth and differentiation. [from MeSH]

MedGen UID:
315661
Concept ID:
C1812630
Biologically Active Substance; Pharmacologic Substance
13.

Neoplasm of the breast

Breast cancer is a disease in which certain cells in the breast become abnormal and multiply uncontrollably to form a tumor. Although breast cancer is much more common in women, this form of cancer can also develop in men. In both women and men, the most common form of breast cancer begins in cells lining the milk ducts (ductal cancer). In women, cancer can also develop in the glands that produce milk (lobular cancer). Most men have little or no lobular tissue, so lobular cancer in men is very rare.In its early stages, breast cancer usually does not cause pain and may exhibit no noticeable symptoms. As the cancer progresses, signs and symptoms can include a lump or thickening in or near the breast; a change in the size or shape of the breast; nipple discharge, tenderness, or retraction (turning inward); and skin irritation, dimpling, or scaliness. However, these changes can occur as part of many different conditions. Having one or more of these symptoms does not mean that a person definitely has breast cancer.In some cases, cancerous tumors can invade surrounding tissue and spread to other parts of the body. If breast cancer spreads, cancerous cells most often appear in the bones, liver, lungs, or brain. Tumors that begin at one site and then spread to other areas of the body are called metastatic cancers.A small percentage of all breast cancers cluster in families. These cancers are described as hereditary and are associated with inherited gene mutations. Hereditary breast cancers tend to develop earlier in life than noninherited (sporadic) cases, and new (primary) tumors are more likely to develop in both breasts.
[from GHR]

MedGen UID:
264172
Concept ID:
C1458155
Neoplastic Process
14.

Angiogenesis Modulating Agents

Agents that modulate the PHYSIOLOGIC ANGIOGENESIS process. This is accomplished by endogenous ANGIOGENIC PROTEINS and a variety of other chemicals and pharmaceutical agents. [from MeSH]

MedGen UID:
263447
Concept ID:
C1257849
Pharmacologic Substance
15.

Angiogenesis inhibitor

Agents and endogenous substances that antagonize or inhibit the development of new blood vessels. [from MeSH]

MedGen UID:
154540
Concept ID:
C0596087
Biologically Active Substance; Pharmacologic Substance
16.

Skin and Connective Tissue Diseases

A collective term for diseases of the skin and its appendages and of connective tissue. [from MeSH]

MedGen UID:
59786
Concept ID:
C0175166
Disease or Syndrome
17.

Neovascularization

MedGen UID:
45041
Concept ID:
C0027686
Pathologic Function
18.

Growth Inhibitors

Endogenous or exogenous substances which inhibit the normal growth of human and animal cells or micro-organisms, as distinguished from those affecting plant growth (= PLANT GROWTH REGULATORS). [from MeSH]

MedGen UID:
42306
Concept ID:
C0018282
Biologically Active Substance; Pharmacologic Substance
19.

Disorder of skin

A disorder involving lesions or eruptions of the skin, usually without inflammation. [from NCI]

MedGen UID:
20777
Concept ID:
C0037274
Disease or Syndrome
20.

Diseases, Respiratory Tract

Diseases involving the RESPIRATORY SYSTEM. [from MeSH]

MedGen UID:
19750
Concept ID:
C0035242
Disease or Syndrome
Format
Items per page

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center